59 research outputs found
Update on Coagulase-Negative Staphylococci—What the Clinician Should Know
Coagulase-negative staphylococci (CoNS) are among the most frequently recovered bacteria
in routine clinical care. Their incidence has steadily increased over the past decades in parallel to
the advancement in medicine, especially in regard to the utilization of foreign body devices. Many
new species have been described within the past years, while clinical information to most of those
species is still sparse. In addition, interspecies differences that render some species more virulent
than others have to be taken into account. The distinct populations in which CoNS infections play a
prominent role are preterm neonates, patients with implanted medical devices, immunodeficient
patients, and those with other relevant comorbidities. Due to the property of CoNS to colonize the
human skin, contamination of blood cultures or other samples occurs frequently. Hence, the main
diagnostic hurdle is to correctly identify the cases in which CoNS are causative agents rather than
contaminants. However, neither phenotypic nor genetic tools have been able to provide a satisfying
solution to this problem. Another dilemma of CoNS in clinical practice pertains to their extensive
antimicrobial resistance profile, especially in healthcare settings. Therefore, true infections caused by
CoNS most often necessitate the use of second-line antimicrobial drugs
Human infections caused by Staphylococcus argenteus in Germany: genetic characterisation and clinical implications of novel species designation
We report a series of Staphylococcus argenteus infections from Saarland, Germany. Travel histories were unremarkable for extra-European sojourns, indicating an autochthonous transmission mode. Multilocus sequence typing revealed that all isolates were members of the clonal complex CC2250. In only one case, guideline-adherent treatment with an isoxazolyl penicillin was prescribed. Our report illustrates the perils of novel species designations, which may lead to misconceptions and suboptimal treatment choices among clinicians
Association between women's authorship and women's editorship in infectious diseases journals : a cross-sectional study
Funding: The European Society of Clinical Microbiology and Infectious Diseases.Background Gender inequity is still pervasive in academic medicine, including journal publishing. We aimed to ascertain the proportion of women among first and last authors and editors in infectious diseases journals and assess the association between women's editorship and women's authorship while controlling for a journal's impact factor. Methods In this cross-sectional study, we randomly selected 40 infectious diseases journals (ten from each 2020 impact factor quartile), 20 obstetrics and gynaecology journals (five from each 2020 impact factor quartile), and 20 cardiology journals (five from each 2020 impact factor quartile) that were indexed in Journal Citation Reports, had an impact factor, had retrievable first and last author names, and had the name of more than one editor listed. We retrieved the names of the first and last authors of all citable articles published by the journals in 2018 and 2019 that counted towards their 2020 impact factor and collected the names of all the journals' editors-in-chief, deputy editors, section editors, and associate editors for the years 2018 and 2019. We used genderize.io to predict the gender of each first author, last author, and editor. The outcomes of interest were the proportions of women first authors and women last authors. We assessed the association between women's editorship and women's authorship by fitting quasi-Poisson regression models comprising the variables: the proportion of women last authors or women first authors; the proportion of women editors; the presence of a woman editor-in-chief; and journal 2020 impact factor. Findings We found 11 027 citable infectious diseases articles, of which 167 (1·5%) had an indeterminable first author gender, 155 (1·4%) had an indeterminable last author gender, and seven (0·1%) had no authors indexed. 5350 (49·3%) of 10 853 first authors whose gender could be determined were predicted to be women and 5503 (50·7%) were predicted to be men. Women accounted for 3788 (34·9%) of 10 865 last authors whose gender could be determined and men accounted for 7077 (65·1%). Of 577 infectious diseases journal editors, 190 (32·9%) were predicted to be women and 387 (67·1%) were predicted to be men. Of the 40 infectious diseases journals, 13 (32·5%) had a woman as editor-in-chief. For infectious diseases journals, the proportion of women editors had a significant effect on women's first authorship (incidence rate ratio 1·32, 95% CI 1·06–1·63; p=0·012) and women's last authorship (1·92, 1·45–2·55; p<0·0001). The presence of a woman editor-in-chief, the proportion of women last or first authors, and the journal's impact factor exerted no effect in these analyses. Interpretation The proportion of women editors appears to influence the proportion of women last and first authors in the analysed infectious diseases journals. These findings might help to explain gender disparities observed in publishing in academic medicine and suggest a need for revised policies towards increasing women's representation among editors.PostprintPeer reviewe
Parenting and caregiving duties as career challenges among clinical microbiologists: a cross-sectional survey
Aim: To estimate the burden of parenting and caregiving duties among clinical microbiologists in
Germany and to identify workplace-related support systems and barriers to engaging in career-relevant
activities. Methods: A cross-sectional web-based survey was conducted. Participants were asked to answer
37 questions, of which 24 specifically addressed parenting and caregiving duties. Results: Only few
workplace-related support systems are currently available, and experiences of job-related disadvantages
were frequently reported (27 of 47; 57.4%). Main barriers were a lack of flexible working hours
and reliable childcare. Sociocultural norms and a lack of role models were perceived as detrimental.
Conclusion: More support systems and a credible culture of family friendliness are needed to prevent
jeopardizing the academic potential of young parents
Staphylococcus massiliensis isolated from human blood cultures, Germany, 2017-2020
Clinical and laboratory data on newly described staphylococcal species is rare, which hampers decision-making when such
pathogens are detected in clinical specimens. Here, we describe Staphylococcus massiliensis detected in three patients at a
university hospital in southwest Germany. We report the discrepancy of microbiological fndings between matrix-assisted
laser desorption/ionization time-of-fight mass spectrometry, 16S-rRNA polymerase chain reaction, and whole-genome
sequencing for all three isolates. Our fndings highlight the diagnostic pitfalls pertinent to novel and non-model organisms
in daily microbiological practice, in whom the correct identifcation is dependent on database accuracy
Aims and challenges of building national trainee networks in clinical microbiology and infectious disease disciplines
Trainees represent the medical practice of tomorrow. Interactions and collaborations at the early stage in career will strengthen the future of our specialties, clinical microbiology and infectious diseases. Trainee networks at the national level help access the best education and career opportunities. The aim of this collaborative white paper between the Trainee Association of European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and four national trainee networks is to discuss the motivation for building such networks and offer guidance for their creation and sustainability even during a health crisis.Publisher PDFPeer reviewe
Antimicrobial Use in Pediatric Oncology and Hematology: Protocol for a Multicenter Point-Prevalence Study With Qualitative Expert Panel Assessment
Background: Because infections are a major driver of morbidity and mortality in children with hematologic or oncologic
diseases, antimicrobials are frequently prescribed in pediatric oncology practice. However, excess or inappropriate use of
antimicrobials is directly linked to the emergence of antimicrobial resistance. Although point-prevalence studies have examined
the extent of antimicrobial use, a comprehensive qualitative evaluation of individual antimicrobial prescriptions remains lacking.
Objective: The aim of this study is to identify appropriate versus inappropriate antimicrobial use among pediatric cancer patients
in a point-prevalence study, followed by an expert panel adjudication process and a subsequent report of these findings to
participating centers. This study also aims to improve the quality of patient care by informing centers about discrepancies between
internal standards of care and national guidelines. Methods: Our point-prevalence study is performed at pediatric cancer centers in Germany and Austria. All patients under 18
years old who are hospitalized at the time of the study are included. As a supplement to the point-prevalence study, an expert
panel is qualitatively assessing each of the antimicrobial prescriptions at the participating centers to review local guidelines and
compare them with national guidelines.
Results: As of December 2021, the point-prevalence survey has been conducted at 30 sites and expert panel adjudication for
qualitative assessment of each antimicrobial use is ongoing. Results of the study are expected in 2022.
Conclusions: This is the first point-prevalence study conducted among pediatric cancer centers with an integrated, multistep,
qualitative approach that assesses each antimicrobial prescription. The results of this study will inform possible interventions for
internal guidelines and antimicrobial stewardship programs implemented at pediatric cancer centers. In addition, local guidelines
will be compared with national guidelines. Furthermore, this study will contribute to the overall integration of antimicrobial
stewardship principles and initiatives in pediatric oncology and hematology, thereby improving safety and quality of care for
children and adolescents with cancer and blood disorders
Expression of TRAIL, IP-10, and CRP in children with suspected COVID-19 and real-life impact of a computational signature on clinical decision-making: a prospective cohort study
Purpose We evaluated the host-response marker score “BV” and its components TRAIL, IP-10, and CRP in SARS-CoV-2
positive children, and estimated the potential impact on clinical decision-making.
Methods We prospectively analyzed levels of TRAIL, IP-10, CRP, and the BV score, in children with suspected COVID19. Classifcation of infectious etiology was performed by an expert panel. We used a 5-point-questionnaire to evaluate the
intention to treat with antibiotics before and after receiving test results.
Results We screened 111 children, of whom 6 (5.4%) were positive for SARS-CoV-2. A total of 53 children were included
for the exploratory analysis. Median age was 3.1 years (interquartile range [IQR] 1.3–4.3), and 54.7% (n=29) were girls.
A viral and a bacterial biomarker pattern was found in 27/53 (50.9%) and 15/53 (28.3%), respectively. BV scores difered
between COVID-19, children with other viral infections, and children with bacterial infections (medians 29.5 vs. 9 vs. 66;
p=0.0006). Similarly, median TRAIL levels were diferent (65.5 vs. 110 vs. 78; p=0.037). We found no diferences in IP-10
levels (555 vs. 504 vs. 285; p=0.22). We found a concordance between physicians’ “unlikely intention to treat” children with
a viral test result in most cases (n=19/24, 79.2%). When physicians expressed a “likely intention to treat” (n=15), BV test
revealed 5 bacterial, viral, and equivocal scores each. Antibiotics were withheld in three cases (20%). Overall, 27/42 (64%)
of pediatricians appraised the BV test positively, and considered it helpful in clinical practice.
Conclusion Host-response based categorization of infectious diseases might help to overcome diagnostic uncertainty, support clinical decision-making and reduce unnecessary antibiotic treatment
Combined antibiotic stewardship and infection control measures to contain the spread of linezolid-resistant Staphylococcus epidermidis in an intensive care unit
Background
The unrestricted use of linezolid has been linked to the emergence of linezolid-resistant Staphylococcus epidermidis (LRSE). We report the effects of combined antibiotic stewardship and infection control measures on the spread of LRSE in an intensive care unit (ICU).
Methods
Microbiological data were reviewed to identify all LRSE detected in clinical samples at an ICU in southwest Germany. Quantitative data on the use of antibiotics with Gram-positive coverage were obtained in defined daily doses (DDD) per 100 patient-days (PD). In addition to infection control measures, an antibiotic stewardship intervention was started in May 2019, focusing on linezolid restriction and promoting vancomycin, wherever needed. We compared data from the pre-intervention period (May 2018–April 2019) to the post-intervention period (May 2019–April 2020). Whole-genome sequencing (WGS) was performed to determine the genetic relatedness of LRSE isolates.
Results
In the pre-intervention period, LRSE were isolated from 31 patients (17 in blood cultures). The average consumption of linezolid and daptomycin decreased from 7.5 DDD/100 PD and 12.3 DDD/100 PD per month in the pre-intervention period to 2.5 DDD/100 PD and 5.7 DDD/100 PD per month in the post-intervention period (p = 0.0022 and 0.0205), respectively. Conversely, vancomycin consumption increased from 0.2 DDD/100 PD per month to 4.7 DDD/100 PD per month (p < 0.0001). In the post-intervention period, LRSE were detected in 6 patients (4 in blood cultures) (p = 0.0065). WGS revealed the predominance of one single clone.
Conclusions
Complementing infection control measures by targeted antibiotic stewardship interventions was beneficial in containing the spread of LRSE in an ICU
- …